TRAPPC4
Trafficking protein particle complex subunit 4
Also known as: PTD009, SBDN, TPPC4_HUMAN, TRS23
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y296
- Gene
- TRAPPC4
- Ensembl
- ENSG00000196655
- Chromosome
- 11
- Canonical length
- 219 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Involved in autophagy and endoplasmic reticulum to Golgi vesicle-mediated transport. Part of TRAPP complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
219 residues, UniProt reviewed canonical sequence.
>Q9Y296|TRAPPC4
1 MAIFSVYVVN KAGGLIYQLD SYAPRAEAEK TFSYPLDLLL KLHDERVLVA FGQRDGIRVG
61 HAVLAINGMD VNGRYTADGK EVLEYLGNPA NYPVSIRFGR PRLTSNEKLM LASMFHSLFA
121 IGSQLSPEQG SSGIEMLETD TFKLHCYQTL TGIKFVVLAD PRQAGIDSLL RKIYEIYSDF
181 ALKNPFYSLE MPIRCELFDQ NLKLALEVAE KAGTFGPGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAPPC4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 37 nTPM
- adrenal gland: 36 nTPM
- kidney: 35 nTPM
- testis: 28 nTPM
- pituitary gland: 28 nTPM
- hypothalamus: 27 nTPM
Single-cell type
- late primary spermatocytes: 57 nCPM
- differentiating spermatogonia: 39 nCPM
- parietal cells: 32 nCPM
- undifferentiated spermatogonia: 30 nCPM
- early spermatids: 27 nCPM
- early primary spermatocytes: 27 nCPM
Immune cell
- T-reg: 97 nTPM
- eosinophil: 77 nTPM
- basophil: 69 nTPM
- total PBMC: 61 nTPM
- memory CD4 T-cell: 60 nTPM
- memory CD8 T-cell: 60 nTPM
Brain region
- hypothalamus: 8.7 nTPM
- white matter: 7.9 nTPM
- choroid plexus: 6 nTPM
- medulla oblongata: 6 nTPM
- spinal cord: 5.9 nTPM
- cerebellum: 5.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRAPPC4.
Disease | AllUniProt
Conditions TRAPPC4 is implicated in, by any mechanism.
- Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (NEDESBA) MIM:618741
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 83 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
- Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies
Disease | ImmuneIEDB
Conditions an epitope on TRAPPC4 was assayed in.
- autoimmune disease of blood B and T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- -0.88
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagy
- COPII vesicle coating
- dendrite development
- endoplasmic reticulum to Golgi vesicle-mediated transport
- vesicle coating
- vesicle tethering
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAPPC4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAPPC4 as an antibody target. Whether an autoantibody or antibody against TRAPPC4 could matter depends on whether native TRAPPC4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAPPC4 is annotated at the cell surface, where native TRAPPC4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRAPPC4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...